GLP-2 receptor agonism ameliorates inflammation and gastrointestinal stasis in murine postoperative ileus

Journal of Pharmacology and Experimental Therapeutics

Volumn 333, Issue 2, 2010, Pages 574-583

  Moore, Beverley A ^a   Peffer, Nancy ^b   Pirone, Allison ^b   Bassiri, Ashlyn ^b   Sague, Sarah ^b   Palmer, Jeffrey M ^a   Johnson, Dana L ^a   Nesspor, Tom ^b   Kliwinski, Connie ^b   Hornby, Pamela J ^b  

^a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT   (United States)

^b CENTOCOR INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; FLUORESCEIN ISOTHIOCYANATE DEXTRAN; GLUCAGON LIKE PEPTIDE 2; GLUCAGON LIKE PEPTIDE 2 RECEPTOR; HORMONE RECEPTOR; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G4; MESSENGER RNA; MYELOPEROXIDASE; PHOSPHATE BUFFERED SALINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; ESOPHAGUS MUSCLE; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; INTESTINAL DYSMOTILITY; INTESTINE SURGERY; LEUKOCYTE; MALE; MOUSE; MUCOSA INFLAMMATION; NONHUMAN; POLYMERASE CHAIN REACTION; POSTOPERATIVE COMPLICATION; POSTOPERATIVE ILEUS; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SINGLE DRUG DOSE;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GASTROINTESTINAL MOTILITY; GENE EXPRESSION; ILEUS; INFLAMMATION; INTESTINE, SMALL; INTESTINES; MALE; MICE; PEROXIDASE; POSTOPERATIVE COMPLICATIONS; RECEPTORS, GLUCAGON;

EID: 77951052304     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.161497     Document Type: Article

References (39)

1. Arthur GL, Schwartz MZ, Kuenzler KA, and Birbe R (2004) Glucagonlike peptide-2 analogue: a possible new approach in the management of inflammatory bowel disease. J Pediatr Surg 39:448-452.
2. Balda MS, Whitney JA, Flores C, Gonzalez S, Cereijido M, and Matter K (1996) Functional dissociation of paracellular permeability and transepithelial electrical resistance and disruption of the apical-basolateral intramembrane diffusion barrier by expression of a mutant tight junction membrane protein. J Cell Biol 134:1031-1049. (Pubitemid 26278226)
3. Bjerknes M and Cheng H (2001) Modulation of specific intestinal epithelial progenitors by enteric neurons. Proc Natl Acad Sci USA 98:12497-12502. (Pubitemid 33019974)
4. Boeckxstaens GE and de Jonge WJ (2009) Neuroimmune mechanisms in postoperative ileus. Gut 58:1300-1311.
5. Cameron HL and Perdue MH (2005) Stress impairs murine intestinal barrier function: improvement by glucagon-like peptide-2. J Pharmacol Exp Ther 314:214-220.
6. Capaldo CT and Nusrat A (2009) Cytokine regulation of tight junctions. Biochim Biophys Acta 1788:864-871.
7. de Jonge WJ, van der Zanden EP, The FO, Bijlsma MF, van Westerloo DJ, Bennink RJ, Berthoud HR, Uematsu S, Akira S, van den Wijngaard RM, et al. (2005) Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 6:844-851.
8. Drucker DJ, Yusta B, Boushey RP, DeForest L, and Brubaker PL (1999) Human [Gly2]GLP-2 reduces the severity of colonic injury in a murine model of experimental colitis. Am J Physiol Gastrointest Liver Physiol276:G79-G91. (Pubitemid 29063603)
9. Estall JL and Drucker DJ (2006) Glucagon-like peptide-2. Annu Rev Nutr26:391-411.
10. Guan X, Karpen HE, Stephens J, Bukowski JT, Niu S, Zhang G, Stoll B, Finegold MJ, Holst JJ, Hadsell D, et al. (2006) GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow. Gastroenterology 130:150-164. (Pubitemid 43049845)
11. Hartmann B, Thulesen J, Kissow H, Thulesen S, Orskov C, Ropke C, Poulsen SS, and Holst JJ (2000) Dipeptidyl peptidase IV inhibition enhances the intestinotrophic effect of glucagon-like peptide-2 in rats and mice. Endocrinology 141:4013-4020.
12. Ivory CP, Wallace LE, McCafferty DM, and Sigalet DL (2008) Interleukin-10 independent anti-inflammatory actions of glucagon-like peptide 2. Am J Physiol Gastrointest Liver Physiol 295:G1202-G1210.
13. L'Heureux MC and Brubaker PL (2003) Glucagon-like peptide-2 and common therapeutics in a murine model of ulcerative colitis. J Pharmacol Exp Ther 306:347-354.
14. Lomax AE, O'Hara JR, Hyland NP, Mawe GM, and Sharkey KA (2006) Persistent alterations to enteric neural signaling in guinea pig colon following resolution of colitis. Am J Physiol Gastrointest Liver Physiol 292:G482-G491. (Pubitemid 46263513)
15. Mardini HE and de Villiers WJ (2008) Teduglutide in intestinal adaptation and repair: light at the end of the tunnel. Expert Opin Investig Drugs 17:945-951.
16. Miller MS, Galligan JJ, and Burks TF (1981) Accurate measurement of intestinal transit in the rat. J Pharmacol Methods 6:211-217. (Pubitemid 12196372)
17. Moon Y, Yang H, and Kim YB (2007) Up-regulation of early growth response gene 1 (EGR-1) via ERK1/2 signals attenuates sulindac sulfide-mediated cytotoxicity in the human intestinal epithelial cells. Toxicol Appl Pharmacol 223:155-163. (Pubitemid 47348058)
18. Moore BA, Albers KM, Davis BM, Grandis JR, Togel S, and Bauer AJ (2007) Altered inflammatory gene expression underlies increased susceptibility to murine postoperative ileus with advancing age. Am J Physiol Gastrointest Liver Physiol 292:G1650-G1659. (Pubitemid 47080589)
19. Natale L, Piepoli AL, De Salvia MA, De Salvatore G, Mitolo CI, Marzullo A, Portincasa P, Moschetta A, Palasciano G, and Mitolo-Chieppa D (2003) Interleukins 1β and 6 induce functional alteration of rat colonic motility: an in vitro study. Eur J Clin Invest 33:704-712. (Pubitemid 36918634)
20. Nelson DW, Sharp JW, Brownfield MS, Raybould HE, and Ney DM (2007) Localization and activation of GLP-2 receptors on vagal afferents in the rat. Endocrinology 148:1954-1962.
21. Orskov C, Hartmann B, Poulsen SS, Thulesen J, Hare KJ, and Holst JJ (2005) GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors. Regul Pept 124:105-112. (Pubitemid 39488347)
22. Picha KM, Cunningham MR, Drucker DJ, Mathur A, Ort T, Scully M, Soderman A, Spinka-Doms T, Stojanovic-Susulic V, Thomas BA, et al. (2008) Protein engineering strategies for sustained glucagon-like peptide-1 receptor-dependent control of glucose homeostasis. Diabetes 57:1926-1934.
23. Schmidt J, Stoffels B, Moore BA, Chanthaphavong RS, Mazie AR, Buchholz BM, and Bauer AJ (2008) Proinflammatory role of leukocyte-derived Egr-1 in the development of murine postoperative ileus. Gastroenterology 135:926-936.
24. Schwarz NT, Beer-Stolz D, Simmons RL, and Bauer AJ (2002) Pathogenesis of paralytic ileus: intestinal manipulation opens a transient pathway between the intestinal lumen and the leukocytic infiltrate of the jejunal muscularis. Ann Surg 235:31-40. (Pubitemid 34062397)
25. Schwarz NT, Kalff JC, Turler A, Engel BM, Watkins SC, Billiar TR, and Bauer AJ (2001) Prostanoid production via COX-2 as a causative mechanism of rodent postoperative ileus. Gastroenterology 121:1354-1371. (Pubitemid 33140453)
26. Shibata C, Naito H, Jin XL, Ueno T, Funayama Y, Fukushima K, Hashimoto A, Matsuno S, and Sasaki I (2001) Effect of glucagon, glicentin, glucagon-like peptide-1 and -2 on interdigestive gastroduodenal motility in dogs with a vagally denervated gastric pouch. Scand J Gastroenterol 36:1049-1055. (Pubitemid 32801689)
27. Sigalet DL, Wallace LE, Holst JJ, Martin GR, Kaji T, Tanaka H, and Sharkey KA (2007) Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide 2. Am J Physiol Gastrointest Liver Physiol 293:G211-G221. (Pubitemid 47105173)
28. Stephens J, Stoll B, Cottrell J, Chang X, Helmrath M, and Burrin DG (2006) Glucagon-like peptide-2 acutely increases proximal small intestinal blood flow in TPN-fed neonatal piglets. Am J Physiol Regul Integr Comp Physiol 290:R283-R289.
29. The FO, Boeckxstaens GE, Snoek SA, Cash JL, Bennink R, Larosa GJ, van den Wijngaard RM, Greaves DR, and de Jonge WJ (2007) Activation of the cholinergic anti-inflammatory pathway ameliorates postoperative ileus in mice. Gastroenterology 133:1219-1228.
30. Thulesen J, Hartmann B, Orskov C, Jeppesen PB, Holst JJ, and Poulsen SS (2000) Potential targets for glucagon-like peptide 2 (GLP-2) in the rat: distribution and binding of i.v. injected (125)I-GLP-2. Peptides 21:1511-1517.
31. Turler A, Kalff JC, Moore BA, Hoffman RA, Billiar TR, Simmons RL, and Bauer AJ (2006) Leukocyte-derived inducible nitric oxide synthase mediates murine postoperative ileus. Ann Surg 244:220-229. (Pubitemid 44305536)
32. Turler A, Schnurr C, Nakao A, Togel S, Moore BA, Murase N, Kalff JC, and Bauer AJ (2007) Endogenous endotoxin participates in causing a panenteric inflammatory ileus after colonic surgery. Ann Surg 245:734-744. (Pubitemid 46684103)
33. Turler A, Schwarz NT, Turler E, Kalff JC, and Bauer AJ (2002) MCP-1 causes leukocyte recruitment and subsequently endotoxemic ileus in rat. Am J Physiol Gastrointest Liver Physiol 282:G145-G155. (Pubitemid 34650109)
34. Wallace LE, Sharkey KA, and Sigalet D (2008) GLP-2 treatment protects against neuronal loss and enhances the expression of VIP in the submucosal plexus in TNBS colitis. Gastroenterology 135:T1378.
35. Wallis K, Walters JR, and Forbes A (2007) Review article: glucagon-like peptide 2-current applications and future directions. Aliment Pharmacol Ther 25:365-372. (Pubitemid 46184449)
36. Wojdemann M, Wettergren A, Hartmann B, and Holst JJ (1998) Glucagon-like peptide-2 inhibits centrally induced antral motility in pigs. Scand J Gastroenterol 33:828-832. (Pubitemid 28423636)
37. Wung BS, Ni CW, and Wang DL (2005) ICAM-1 induction by TNFα and IL-6 is mediated by distinct pathways via Rac in endothelial cells. J Biomed Sci 12:91-101.
38. Yusta B, Boushey RP, and Drucker DJ (2000) The glucagon-like peptide-2 receptor mediates direct inhibition of cellular apoptosis via a cAMP-dependent protein kinase-independent pathway. J Biol Chem 275:35345-35352.
39. Zhang W, Zhu W, Zhang J, Li N, and Li J (2008) Protective effects of glucagon-like peptide 2 on intestinal ischemia-reperfusion rats. Microsurgery 28:285-290. (Pubitemid 351770173)